COVID-19 and SARS-CoV-2 Archives

CDC Merges Influenza, Coronavirus Divisions Into Unified Respiratory Unit

Sep 11, 2026 | Coronavirus, Healthcare & Policy, Influenza

The federal agency restructured its flu and COVID-19 units into a unified Influenza and Respiratory Viruses Division (IRVD).

IDSA Concerned Over Federal Plan to Overhaul Infectious Disease Research

Sep 4, 2026 | Healthcare & Policy, Influenza, Other Infections

Leading medical societies warn that proposed changes and funding delays at the National Institutes of Health could disrupt active studies and patient care.

AAP Updates RSV, COVID-19 Vaccine Recommendations

Sep 3, 2026 | Coronavirus, Influenza, Neonatal, Pediatric Care, RSV

AAP recommendations expand second-season RSV protection criteria for children ages 8 to 19 months, alongside updated infant COVID-19 vaccination recommendations.

IDSA Issues Vaccine Recommendations for 2026-2027

Sep 3, 2026 | Coronavirus, Influenza, Other Infections, RSV

New clinical recommendations emphasize the safety and importance of COVID-19, influenza, and RSV vaccines for individuals with weakened immune systems.

FDA Approves Updated COVID-19 Vaccines for 2026-2027

Sep 2, 2026 | Coronavirus, FDA Approvals, US Pharmaceuticals

Updated formulas from Pfizer, Moderna, and Novavax target the circulating XFG variant for older adults and high-risk populations.

CVS, Walgreens Now Offering Seasonal Flu Vaccines

Aug 31, 2026 | Influenza, US Pharmaceuticals

CVS and Walgreens are expanding walk-in access, multi-vaccine scheduling, and respiratory illness testing ahead of peak viral activity.

COVID-19 Alters Sleep Breathing Patterns

Aug 25, 2026 | Coronavirus, Sleep Apnea

People with a COVID-19 history showed a significantly stronger breathing response following brief arousals from sleep.

NFID Initiative to Improve Respiratory Disease Prevention Messaging

Aug 18, 2026 | Coronavirus, Influenza, Other Infections, RSV

The National Foundation for Infectious Diseases (NFID) launched an initiative to streamline evidence-based information regarding respiratory disease prevention.

SARS-CoV-2 Protein Linked to Severe Inflammation

Aug 14, 2026 | Coronavirus

Researchers discovered the nucleocapsid protein of SARS-CoV-2 triggers hyperinflammation in immune cells, potentially leading to vascular leakage in the heart and brain.

Cancer Vaccine Platform Uses COVID-19 Immune Memory to Fight Tumors

Jul 27, 2026 | Coronavirus, Lung Cancer

Researchers developed a system that redirects pre-existing antiviral signals to help the immune system recognize and attack cancer cells.

COVID-19 Pandemic Shifted Timing of Seasonal Respiratory Surges

Jul 15, 2026 | Coronavirus, Influenza, RSV

A study shows that a loss of immunity caused flu and RSV peaks to occur earlier in the season before returning to pre-pandemic patterns.

COVID‑19 Cicada Variant Spreads

Jul 7, 2026 | Coronavirus

The BA.3.2 variant of COVID-19, nicknamed Cicada, features significant genetic changes that may impact vaccine effectiveness for patients with chronic lung disease.

Long COVID Patients Benefit from Cognitive Therapy

Jul 3, 2026 | Coronavirus, Pulmonary Rehab

Patients with long COVID receiving individualized cognitive rehab showed significantly higher goal attainment scores at three months compared to standard care.

HHS Ends COVID-19 Emergency Use Authorizations

Jul 3, 2026 | FDA Approvals, General Healthcare, Recalls & Advisories, Therapy Devices, US Pharmaceuticals

HHS secretary Robert F Kennedy, Jr signed determinations to end COVID-19 emergency use authorizations for drugs, biological products, and medical devices because the emergency circumstances no longer exist.

FDA Clears AMDI Fast PCR Respiratory Panel for Point-of-Care Testing

Jul 1, 2026 | Coronavirus, FDA Approvals, Influenza, RSV, Testing

The AMDI Fast PCR System provides point-of-care results for RSV, influenza, and COVID-19 in less than 10 minutes.

Cystic Fibrosis Care Still Below Pre-Pandemic Levels

Jun 30, 2026 | Cystic fibrosis

New data shows that patient visits and lung function tests for cystic fibrosis have not returned to 2019 levels despite new treatments and telehealth options.

Same-Day COVID-19 and Flu Vaccines Are Safe for Adults

Jun 30, 2026 | Coronavirus, Influenza, US Pharmaceuticals

Research involving 2.5 million patients found no increase in serious adverse events when receiving both COVID-19 and influenza vaccinations during the same visit.

Tech-funded Project Intercept Aims to Strike Down Cold and Flu

Jun 25, 2026 | Influenza, Other Infections

Backed by approximately $500 million in investment from Big Tech, the Intercept initiative will back broad-spectrum preventatives and air-cleaning technologies to reduce the global health burden of respiratory infections.